Iron Leaf Capital Corp IRON 深 沪
等待开盘 08-05 09:30:00 美东时间
59.79
+0.820
+1.39%
华盛通- 最 高59.98
- 今 开58.93
- 成交量 30.64万股
- 最 低 58.29
- 昨 收 58.97
- 总市值 20.71亿
- 52周最高 68.73
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 30.82
- 委 比 46.04%
- 总股本 3463.43万
- 历史最高 190.85
- 量 比 0.97
- 振 幅 2.87%
- 历史最低 11.60
- 每 手 1
- 风险率 11.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多独家 | 小鹏机器人新成立智能拟态部 主攻机器人多模态
新浪科技讯 7月25日下午消息，新浪科技获悉，小鹏机器人中心新成立智能拟态部，主攻机器人多模态，研究方向包括具身智能原生多模态大模型、世界模型、空间智能等...
07-25 16:56
首台印尼本地生产小鹏X9完成交付！小鹏全球本地化战略正式启航
近日，小鹏汽车首次亮相东南亚最大的汽车盛会2025年印尼国际汽车展（简称“GIIAS 2025”）。 在展会现场，小鹏汽车正式宣布，印尼成为小鹏汽车在全球首个落...
07-24 10:07
Truist Securities Initiates Coverage On Disc Medicine with Buy Rating, Announces Price Target of $86
Truist Securities analyst Danielle Brill initiates coverage on Disc Medicine (NASDAQ:IRON) with a Buy rating and announces Price Target of $86.
07-21 20:10
Disc Medicine Announces Positive Pre-NDA Meeting and Confirms Plans to Submit NDA for Bitopertin in Erythropoietic Protoporphyria (EPP) in October 2025
Disc Medicine announced positive feedback from its pre-NDA meeting with the FDA for bitopertin in EPP, confirming alignment on the planned NDA submission in October 2025 under the FDA’s accelerated approval pathway. Bitopertin, an investigational GlyT1 inhibitor, aims to modulate heme biosynthesis and could be the first disease-modifying therapy for EPP, a rare, debilitating disease causing severe sun-related reactions and complications.
07-21 12:00
Disc Medicine Elects Nadim Ahmed as Director
Disc Medicine ( ($IRON) ) has provided an announcement. On July 9, 2025, Disc M...
07-14 20:58
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
Disc Medicine announced the appointment of Nadim Ahmed, CEO of Cullinan Therapeutics, to its Board of Directors. Ahmed brings over 25 years of experience in drug development and commercialization, particularly in hematology. His加入 is expected to supportDisc Medicine's efforts to advance its lead candidate, bitopertin, toward commercialization for EPP, alongside expanding its hematology pipeline.
07-14 12:30
Morgan Stanley Assumes Disc Medicine at Overweight, Announces Price Target of $85
Morgan Stanley analyst Sean Laaman assumes Disc Medicine (NASDAQ:IRON) with a Overweight rating and announces Price Target of $85.
07-04 01:41
何小鹏：小鹏今年上半年销量已超2024年全年，飞行汽车和人形机器人2026年量产
新浪科技讯 7月3日晚间消息，在今日的小鹏G7上市发布会上，小鹏汽车董事长、CEO何小鹏发表演讲。 他表示，2025上半年，小鹏汽车累计交付19718...
07-03 19:45
小鹏汽车6月共交付新车34,611台，2025上半年累计交付197,189台，超...
今日，小鹏汽车公布最新交付成绩。2025年6月，小鹏汽车共交付新车34,611台，同比增长224%，连续8个月交付量超3万台。2025年第二季度，小鹏汽车累计交...
07-01 13:02
